STEALTH BIOTHERAPEUTICS INC. – Trademark Portfolio
Entity Type: 03
STEALTH BIOTHERAPEUTICS INC. holds 36 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 30 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 7 Nice Classification classes. Currently, 1 trademark is registered and 18 are pending. The owner is based in Needham, MA.
Suite 201
123 Highland Ave
Needham, MA 02494
Showing of trademarks Trademarks
Trademark Classifications
STEALTH BIOTHERAPEUTICS INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does STEALTH BIOTHERAPEUTICS INC. have?
STEALTH BIOTHERAPEUTICS INC. has 36 U.S. trademarks filed with the USPTO. Of these, 1 registered, 18 pending, 16 abandoned, 1 cancelled.
What trademark classes does STEALTH BIOTHERAPEUTICS INC. file in?
STEALTH BIOTHERAPEUTICS INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is STEALTH BIOTHERAPEUTICS INC.'s trademark registration success rate?
STEALTH BIOTHERAPEUTICS INC. has a 6% trademark registration rate, with 1 out of 18 resolved applications resulting in successful registration. Currently, 18 applications are pending review.